Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2010
04/27/2010US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer
04/27/2010US7704947 Methods and compositions for the treatment of gastrointestinal disorders
04/27/2010US7704710 Expression vectors; transformed host cells; culturing the host cell to produce the encoded polypeptide; antiasthmatic agents
04/27/2010US7704526 Sustained release composition for oral administration of drugs
04/27/2010US7704506 Fcε-PE chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
04/27/2010CA2461354C Fondant-based pharmaceutical composition
04/27/2010CA2422378C Pyrazole compounds useful as protein kinase inhibitors
04/27/2010CA2413857C Pd-l2 molecules: pd-1 ligands and uses therefor
04/27/2010CA2321951C Dietary control of arachidonic acid metabolism
04/22/2010WO2010045311A1 Methods of using nitrogen-containing heterocycle derivatives
04/22/2010WO2010045209A2 Methods of treating pulmonary disorders with liposomal amikacin formulations
04/22/2010WO2010045166A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010WO2010043981A1 Method for treatment of copd and other pulmonary diseases
04/22/2010WO2010043000A1 S1p receptors modulators and their use thereof
04/22/2010WO2010042970A1 A method of vaccination pigs
04/22/2010WO2010018113A3 Bi-aryl aminotetralines
04/22/2010WO2010018112A3 Monoaryl aminotetralines
04/22/2010WO2009158309A3 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
04/22/2010WO2009043450A8 Use of neurotrophic factor for retinal cholinergic neurons (nfrcn) and chorionic gonadotropin-beta (109-145) as therapeutic agents
04/22/2010US20100099728 Spiro-oxindole compounds and their use as therapeutic agents
04/22/2010US20100099722 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives
04/22/2010US20100099708 Piperidine Derivative Used for Treating Chemokine Receptor 5 Mediated Diseases
04/22/2010US20100099691 Pyrimidinyl pyridone inhibitors of jnk
04/22/2010US20100099680 Pteridinone derivatives as p13-kinases inhibitors
04/22/2010US20100099665 Isoquinolinone derivatives
04/22/2010US20100099654 Fatty acid esters of glucocorticoids as anti-inflammatory and anti-cancer agents
04/22/2010US20100099653 Particle Size Reduction Apparatus, and Use Thereof
04/22/2010US20100099651 Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
04/22/2010US20100099643 Fused Pentacyclic Polyethers
04/22/2010US20100099630 Method for improving ventilatory efficiency
04/22/2010US20100098790 Combination herbal product to benefit respiratory tract
04/22/2010US20100098687 Compositions and methods for treating thymic stromal lymphopoietin (tslp)-mediated conditions
04/22/2010US20100098659 Compositions and methods for treating matrix metalloproteinase 9 (mmp9)-mediated conditions
04/22/2010US20100098642 Optimised formulation of tobramycin for aerosolization
04/22/2010US20100095963 Pharmaceutical compositions
04/22/2010CA2740696A1 Heterocyclic benzimidazoles as trpm8 modulators
04/22/2010CA2740484A1 S1p receptors modulators and their use thereof
04/22/2010CA2740360A1 Method for treatment of copd and other pulmonary diseases
04/22/2010CA2739954A1 Methods of treating pulmonary disorders with liposomal amikacin formulations
04/21/2010EP2177513A1 Phenylacetic acid compound
04/21/2010EP2177511A2 Process for preparing 3,6-disubstituted azabicyclo derivatives
04/21/2010EP2177231A2 Use of goat serum for veterinary treatment
04/21/2010EP2176240A1 Amine salts of a crth2 antagonist
04/21/2010EP2176238A1 Morpholino pyrimidine derivatives used in diseases linked to mtor kinase and/or pi3k
04/21/2010EP1888584B1 1, 6 -dihydro- 1,3, 5, 6-tetraaza-as-indacene based tricyclic compounds and pharmaceutical compositions comprising same as inhibitors of ikk enzyme activity
04/21/2010EP1761494B1 Chemical compounds i
04/21/2010EP1610780B1 Cyclic protein tyrosine kinase inhibitors
04/21/2010EP1272175B1 N,n'-diaryl guanidines as il-8 receptor antagonists
04/21/2010CN1923820B Novel carboxylic acid derivatives, their preparation and use
04/21/2010CN1857608B Preparation of senile dyspneic cough treating capsule
04/21/2010CN1740169B Arylmethylamine derivatives for use as tryptase inhibitors
04/21/2010CN1689628B Medical purpose of creat extract
04/21/2010CN101696243A Human genetic engineering antibody TRD 109 as well as preparation method and application thereof
04/21/2010CN101696205A 3-(substituted xylylenimine-2-yl)-2,6-dioxopiperidine polymorph and pharmaceutical composition
04/21/2010CN101696166A Preparation method for danshen root salvianolic acid A
04/21/2010CN101695563A Particles and powders for preventing and treating chronic bronchitis and cor pulmonale
04/21/2010CN101695553A Cough-relieving pear sugar Chinese medicinal paste
04/21/2010CN101695551A Granules or powder for promoting and helping digestion and preventing tracheitis
04/21/2010CN101695548A Olive traditional Chinese ointment beneficial to pharynx
04/21/2010CN101695535A Chinese medicinal herb composition for treating chronic pharyngitis
04/21/2010CN101695519A Chinese medicament for treating nasosinusitis
04/21/2010CN101695512A Banlangen buccal tablet and preparation method thereof
04/21/2010CN101327208B Use of Carthamus tinctorius yellow colour in preparing medicament for treating and/or preventing lung damnification
04/21/2010CN101229343B Chinese traditional medicine for treating pulmonary tuberculosis
04/21/2010CN101181365B Chinese medicine composition orally taken for curing tonsillitis
04/21/2010CN101168000B Method for preparing medicine for treating pulmonary tuberculosis and quality standard detecting method
04/21/2010CN101164613B Proprietary Chinese medicine for treating rhinitis
04/21/2010CN101152465B Oral liquid for anti-fever and smoothing asthma of hyperpyrexia syndrome and its preparation method
04/21/2010CN101129358B Moguisteine sustained-release tablet and method of preparing the same
04/20/2010US7700657 Vitamin D analogs
04/20/2010US7700655 Antiallergic agents
04/20/2010US7700610 Use of tyrosine kinase inhibitors for treating allergic diseases
04/20/2010US7700604 (5S)-5-methyl-5-({[6-[2-(trifluoromethyl)pyrimidin-5-yl]-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)imidazolidine-2,4-dione; asthma, rhinitis, chronic obstructive pulmonary diseases (COPD), arthritis (such as rheumatoid arthritis and osteoarthritis), atherosclerosis, cancer
04/20/2010US7700586 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
04/20/2010US7700558 Methods for treating diabetes using fibroblast growth factor-like polypeptides
04/20/2010US7700271 Method of diagnosis and treatment and agents useful for same
04/20/2010US7700092 Pneumovirus NS proteins antagonize the interferon IFN response
04/20/2010US7700088 Interleukin-9 mutein peptides
04/20/2010CA2561950C 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors
04/20/2010CA2417475C Composes azabicycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacterien
04/20/2010CA2362331C Epoxide hydrolase complexes and methods therewith
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/15/2010WO2010042652A2 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
04/15/2010WO2010042549A1 Inhalation of levofloxacin for reducing lung inflammation
04/15/2010WO2010042477A1 Benzodioxan analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010042475A1 Spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010042473A1 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators
04/15/2010WO2010041711A1 Isoquinoline derivative, and pde inhibitor comprising same as active ingredient
04/15/2010WO2010040992A1 Quinoline derivatives having dp and / or crth2 receptor activity
04/15/2010WO2010003127A3 Antagonists of prostaglandin d2 receptors
04/15/2010US20100093830 Modulation of MLCK-L Expression and Uses Thereof
04/15/2010US20100093816 [2-(4-chloro-benzyloxy)-ethyl]-[2-((R)-cyclohexyl-hydroxy-phenyl-methyl)-oxazol-5-ylmethyl]-dimethyl-ammonium napadisylate for treating chronic obstructive pulmonary disease
04/15/2010US20100093813 Salts 668
04/15/2010US20100093783 Composition for treatment of common cold
04/15/2010US20100093782 Pyrazolonaphthyridine derivatives
04/15/2010US20100093774 5-substituted quinazolinone derivatives and compositions comprising and methods of using the same
04/15/2010US20100093769 Compounds
04/15/2010US20100093753 Biphenyl compounds useful as muscarinic receptor antagonists
04/15/2010US20100093751 Indolizineacetic Acids and Their Therapeutic Use as Ligands of the CRTH2 Receptor
04/15/2010US20100093740 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives
1 ... 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 ... 878